Crowdly
Add to Chrome
VaccinesRUs is a biotech start up. Clinical trials of its product will start nex...
✅ The verified answer to this question is available below. Our community-reviewed solutions help you understand the material better.
VaccinesRUs is a biotech start up. Clinical trials of its product will start next year and if trials are successful, authorisation to market their product will be given for the following year (year 2). Analysts expect VaccinesRUs to start paying dividends in five-years’ time, and the first dividend is expected to be 25p per share. Dividends are predicted to grow at 3% per year. If the discount rate is 8%, what is today’s share price?
0%
0%
0%
0%
❌